Form 4: Omeros Corp Director Thomas F. Bumol Receives Stock Option Award

Director Thomas F. Bumol was granted a stock option to purchase 15,000 shares of Omeros Corp common stock on June 6, 2024, as part of the company's non-employee director compensation policy.

Summary

• On June 6, 2024, Thomas F. Bumol, a director of Omeros Corporation, was granted a stock option to purchase 15,000 shares of the company's common stock.
• The grant was made pursuant to Omeros Corporation's non-employee director compensation policy.
• The option has an exercise price of $3.91.
• The option will fully vest and become exercisable on the day before the date of the 2025 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.
• The option expires on June 6, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The grant of stock options to a director is a routine corporate governance practice and generally viewed as a positive incentive.

Positives

• The stock option grant aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service as a director.

Future Outlook

The document does not contain any specific forward-looking statements beyond the vesting schedule of the stock option.

Industry Context

Stock option grants are a common form of compensation for non-employee directors, aligning their interests with the long-term performance of the company. This practice is widespread across the biotechnology industry.

Comparison to Industry Standards

• Director compensation packages, including stock options, vary significantly across the biotechnology industry depending on company size, stage of development, and performance.
• Companies like Amgen, Gilead Sciences, and Regeneron Pharmaceuticals typically offer more substantial equity grants to their directors due to their larger market capitalization and revenue generation.
• Smaller biotech companies, like Omeros, often use stock options to conserve cash while still providing directors with a meaningful stake in the company's success.

Stakeholder Impact

• Shareholders: The stock option grant aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
• Employees: The grant does not directly impact employees.

Key Dates